Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/31/25 16:05 | 7/30/25 | CRDF | Health | BioPrd | Biological Products, (No Diag | Pace Gary W | CA | D | P | 711 | 2.45 | 0 | 290 | 12 | 2,676 | M | |||||||||||||||
12/18/24 16:37 | 12/16/24 | CRDF | Health | BioPrd | Biological Products, (No Diag | Levine James E. | CA | O | CFO | P.m | 37 | 4.76 | 0 | 8 | 13 | 68 | I | ||||||||||||||
12/16/24 17:00 | 12/12/24 | CRDF | Health | BioPrd | Biological Products, (No Diag | Tannenbaum Renee P | CA | D | P | 34 | 3.42 | 0 | 10 | 100 | 20 | D | |||||||||||||||
12/12/24 16:05 | 12/11/24 | CRDF | Health | BioPrd | Biological Products, (No Diag | Pace Gary W | CA | D | P | 940 | 2.60 | 0 | 362 | 21 | 2,107 | M | |||||||||||||||
12/19/23 18:39 | 12/19/23 | CRDF | Health | BioPrd | Biological Products, (No Diag | Pace Gary W | CA | D | P | 41 | 1.37 | 0 | 30 | 4 | 698 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |